Abatacept Use Is Associated with Steroid Dose Reduction and Improvement in Fatigue and CD4-Dysregulation in CVID Patients with Interstitial Lung Disease
Caroline von Spee-Mayer, Constanze Echternach, Prerana Agarwal, Sylvia Gutenberger, Veronika Soetedjo, Sigune Goldacker, Klaus Warnatz
Topics & Concepts
MedicineAbataceptInterstitial lung diseaseInternal medicineDiseaseLungRituximabLymphomaImmunodeficiency and Autoimmune DisordersInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisAsthma and respiratory diseases